The presence of metalloproteinase activity in endometrial flushings obtained from premenopausal women, during the proliferative and secretory phases of the menstrual cycle, control post-menopausal women and women with post-menopausal bleeding (PMB) with or without adenocarcinoma was analysed by zymography. In addition, quantitative measurements of matrix metalloproteinase 2 (MMP-2), and tissue inhibitor of metalloproteinase 1 (TIMP-1) in the flushings were obtained by ELISA. The zymography results showed eight bands of activity, with molecular weights ranging from 51 to 208 kDa in the flushings from pre-menopausal women and post \ x=req-\ menopausal women, particularly those with adenocarcinoma. Both zymography and ELISA showed that MMP-2 and MMP-9 were the major metalloproteinases found in the flushings and only low concentrations of MMP-3 were found. Concentrations of MMP\x=req-\ 2 in pre-menopausal women were higher in flushings obtained during the secretory phase of the menstrual cycle than those obtained in the proliferative phase (P < 0.05), suggesting that it may play a role in embryo implantation. Concentrations of MMP-2 (P< 0.001), MMP-9 (P<0.05) and TIMP-1 (P < 0.001) in the flushings from post \ x=r eq-\ menopausal control women were lower than those from pre-menopausal women. Concentrations of MMP-2 (P < 0.05) and TIMP-1 (P < 0.05) were higher in flushings from women with PMB without carcinoma compared with post-menopausal controls and concentrations of MMP-9 (P < 0.01) and TIMP-1 (P < 0.05) in flushings from women with adenocarcinoma were higher than in post-menopausal controls. Among subjects with PMB, concentrations of MMP-9 in women with adenocarcinoma were higher than those without carcinoma (P < 0.05). Our results show that concentrations of MMP-2, MMP-9 and TIMP-1, but not MMP-3, are associated with endometrial activity and, therefore, may have a role in the breakdown of endometrial tissue. In addition, the increased concentrations of MMP-9 in flushings of women with adenocarcinoma indicate that this particular proteinase is associated with the presence of endometrial neoplastic cells.
Introduction
Matrix metalloproteinases (MMPs) are a family of zincdependent endopeptidases that possess proteolytic activities against several components of the extracellular matrix (Hulboy et al, 1997) . They are secreted as inactive proenzymes which become activated by removal of an aminoterminal peptide. The function of the active enzyme is to digest the extracellular matrix. They are divided into collagenases, gelatinases or stromelysins according to their substrate specificity. Collagenases, such as MMP-1 and MMP-8, digest collagen type I, II, III, VII and X; gelatinases, such as MMP-2 and MMP-9, digest collagen type IV and denatured collagen (gelatin); stromelysins, including MMP-3, and MMP-10, degrade a variety of extracellular matrix components such as fibronectin, proteoglycans, laminin and collagen types IV, V and VII. The activity of these enzymes is inhibited by various tissue inhibitors of metalloproteinases (TIMPs) . TIMP-1 forms stoichiometric complexes with active forms of all known MMPs and in addition binds pro-MMP-2. TIMP-2 shows similar inhibitory activity to TIMP-1 against MMPs but preferentially binds with MMP-2 (Zhang and Salamonsen, 1997 Salamonsen, 1997) . Expression of other metalloproteinases appears to decrease during the early secretory phase of the menstrual cycle but concentrations then increase again at the end of the cycle, when they may have a role in the breakdown of endometrial tissue before and during menstruation (Rodgers et al, 1993; Marbaix et al, 1995) . Endometrial MMPs, particularly MMP-2 and MMP-9, are also postulated to have a role in the breakdown of the subepithelial basement membrane in embryo implantation and further breakdown of extracellular matrix molecules in cytotrophoblast invasion (Martelli et al., 1993; Bischof et al., 1995) .
Other studies have suggested the importance of MMPs and their inhibitors in the invasive properties of cancer cells (Liotta et al., 1980; Ponton et al., 1991) and a recent study has indicated that high concentrations of MMP-2 and MMP-9 are expressed by endometrial carcinoma cells (Tamakoshi et al., 1995 
Materials and Methods

Human subjects
Uterine flushing samples were obtained from four groups of women for this study.
(1) The first group were pre-menopausal normal fertile women volunteers. The ten women in this group were aged between 23 and 38 years and had regular menstrual cycles of between 25 and 35 days. None of the women had taken any steroid hormones for 2 months before the study. The mean number of children was 2.1 (range 1-4). For each subject a uterine flushing was obtained on day (Table 2) indicates that some women with adenocarcinoma had extremely high concentrations of MMP-2 and MMP-9 in their uterine flushings. cells. Although the flushing samples used in this and our previous studies appear to show no tissue contamination, to minimise the possibility of the contribution of endometrial tissue to the proteins measured, the flushings were centrifuged on collection and the supernatants frozen immediately. Previous studies have suggested that uterine fluids contain plasma proteins such as albumin (Shirai et al., 1972) . However, in these studies it was acknowledged that the flushings were contaminated with blood, which may have been the source of albumin found. Although for the majority of our flushings there was no such contamination, it is possible that the MMPs and TIMP-1 measured in the flushings may have resulted from transfer from the blood through the stromal and epithelial cell compartments into the luminal cavity.
Protein estimations carried out on the flushing samples obtained from the various groups of women showed that concentrations in post-menopausal control women were lower than those in pre-menopausal women, which probably reflect the decrease in endometrial secretory activity in these women. Concentrations of protein in the flushings from premenopausal women in this study were ten times higher than those seen in a previous study (Dawood and Fazleabas, 1986 ). In the earlier study the protein concentration was measured in a 10 ml flushing whereas in this study a 1 ml flushing was obtained. The 10-fold difference in results therefore suggests that both studies are showing similar endometrial protein production. In contrast to this earlier study, no increase in protein concentration was seen in secretory phase flushings in the study reported here. Protein concentrations were higher in women with post-menopausal bleeding (PMB) than in both pre-menopausal women and control post-menopausal women. However, the fact that no correlation was seen between concentrations of MMPs and TIMP-1 in flushings and protein concentrations in any group of women indicates that the specific concentrations of these proteins in the flushings is independent of total protein concentration.
The zymography results obtained in this study showed eight distinct bands of proteinase activity in the flushings from pre-menopausal women corresponding to molecular masses of approximately 208, 143, 123, 98, 90, 73, 67 and 51 kDa. A similar pattern of bands has been reported in the supernatants from cultured stromal and epithelial cells (Martelli et al., 1993 (Irwin et al, 1996; Hulboy et al, 1997) . Other workers have postulated that MMP-2 and MMP-9 may play a role in embryo implantation (Bischof et al, 1995 (Martelli et al, 1993) and that epithelial cells may produce the lower molecular weight MMPs (Martelli et al, 1993; Rodgers et al, 1994) . Our previous studies using endometrial flushings have been on epithelial cell products, which would be expected to be secreted into the lumen of the endometrium. It is possible that stromal cell products may not be secreted into the uterine cavity and that MMPs may be specifically retained by binding to extracellular matrix components, and therefore concentrations in endometrial flushings may reflect the secretion of these proteins by the endometrium less accurately than has previously been shown for epithelial cell products (Li et al., 1993; Dalton et al., 1995; Hey et al, 1995) .
This may be another reason for some of the differences in our results and those of others.
concentrations of MMP-2, MMP-9 and TIMP-1 proteins, but not of MMP-3, are associated with endometrial activity and therefore may have a role in the breakdown of endometrial tissue. In addition, MMP-9 is increased in women with PMB and adenocarcinoma, indicating that it may be produced by endometrial neoplastic cells.
